Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on June 11, 2025
Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions
GlobeNewswire
·
June 11, 2025
RA'ANANA, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, announced today that its FDA- …
Majority of Diagnostic Laboratory Leaders Bet Big on Digital Pathology and AI
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to advancing precision medicine. This perspective comes as organizations across the sector prioritize …
Project 55 Launches Free Mental Health First Responder Training for Public Use
GlobeNewswire
·
June 11, 2025
Project 55 Logo LADERA RANCH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Project 55, a nonprofit organization focused on improving mental health outcomes in the workplace, is launching its Mental Health First Responder Training—a no-cost, online program …
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
GlobeNewswire
·
June 11, 2025
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® -- ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs …
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE ( …
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, today announced the addition of two senior leadership hires. Vanessa Tolosa, PhD, a Neuralink co-founder and …
The Joint Commission and Coalition for Health AI Join Forces to Scale the Responsible Use of AI in Delivering Better Healthcare
GlobeNewswire
·
June 11, 2025
OAKBROOK TERRACE, Illinois, June 11, 2025 (GLOBE NEWSWIRE) -- The Joint Commission, an independent, evidence-based healthcare standard setting organization, and the Coalition for Health AI (CHAI), a nonprofit organization founded by clinicians to advance …
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program
GlobeNewswire
·
June 11, 2025
BEIJING, June 11, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced that Ms. Jennifer Zhan, the Company’s chief executive …
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
GlobeNewswire
·
June 11, 2025
Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to $1.5 billion over the life of the drug …
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
GlobeNewswire
·
June 11, 2025
SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and …
Veru to Participate in the Virtual BTIG Obesity Health Forum
GlobeNewswire
·
June 11, 2025
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company …
Lisata Therapeutics to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 11, 2025
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
GlobeNewswire
·
June 11, 2025
Delray Beach, FL, June 11, 2025 (GLOBE NEWSWIRE) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted …
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
GlobeNewswire
·
June 11, 2025
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connection with planned …
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
GlobeNewswire
·
June 11, 2025
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes Vivos’ business model pivot to target high patient volume …
Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th
GlobeNewswire
·
June 11, 2025
WHITE BEAR LAKE, Minn., June 11, 2025 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announced that …
Artelo Biosciences Announces Reverse Stock Split
GlobeNewswire
·
June 11, 2025
SOLANA BEACH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
OKYO Pharma to Present at the Bio International Convention
GlobeNewswire
·
June 11, 2025
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic Evolution and Renewed Vision
GlobeNewswire
·
June 11, 2025
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) -- IntelGenx, a leader in oral thin film drug delivery, today announced its official rebrand to Nualtis, marking a pivotal step in the company’s transformation and long-term strategic vision. The name Nualtis blends …
AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
GlobeNewswire
·
June 11, 2025
SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a new United States Department of Defense (DoD) grant has …